Medicines: the keys behind price increases and the "PAMI distortion" Remedies rose 146% between November and February, according to a report from the Center for Pharmaceutical Professionals. In the second month of the year, 11.5 million fewer units were sold than in the same period of 2023.
The reasons behind the strong increases in the values and role of agreements with PAMI are not clear. The only pharmaceutical industry chamber that had responded to this media's queries was CILFA, an entity that brings together the largest national laboratories.